Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Titel:
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Auteur:
Dreyling, Martin Doorduijn, Jeanette Giné, Eva Jerkeman, Mats Walewski, Jan Hutchings, Martin Mey, Ulrich Riise, Jon Trneny, Marek Vergote, Vibeke Shpilberg, Ofer Gomes da Silva, Maria Leppä, Sirpa Jiang, Linmiao Stilgenbauer, Stephan Kerkhoff, Andrea Jachimowicz, Ron D Celli, Melania Hess, Georg Arcaini, Luca Visco, Carlo van Meerten, Tom Wirths, Stefan Zinzani, Pier Luigi Novak, Urban Herhaus, Peter Benedetti, Fabio Sonnevi, Kristina Hanoun, Christine Hänel, Matthias Dierlamm, Judith Pott, Christiane Klapper, Wolfram Gözel, Döndü Schmidt, Christian Unterhalt, Michael Ladetto, Marco Hoster, Eva
Verschenen in:
Lancet
Paginering:
Jaargang 403 () nr. 10441 pagina's 2293-2306
Jaar:
2024
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license